Patient Activists are Speaking Out After NHS England Decided Not to Fund a Drug to Treat TSC-Associated Epilepsy
The National Health Service (NHS) England is facing criticism following their decision not to fund the drug everolimus as a treatment for tuberous sclerosis complex associated refractory epilepsy. In comparison,…